Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo.
- DOI
- 10.2147/clep.s509873
- Published
- 2025-04-17
- Container
- Clin Epidemiol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/clep.s509873,
title = {Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo.},
author = {Borgquist S and Jensen MB and Bendorff CL and Christiansen P and Offersen BV and Kodahl AR and Ewertz M and Jensen AB and Ahern TP and Cronin-Fenton D and Ejlertsen B and Danish Breast Cancer Group.},
year = {2025},
journal = {Clin Epidemiol},
doi = {10.2147/clep.s509873},
url = {https://doi.org/10.2147/clep.s509873}
}RIS
TY - JOUR TI - Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo. AU - Borgquist S AU - Jensen MB AU - Bendorff CL AU - Christiansen P AU - Offersen BV AU - Kodahl AR AU - Ewertz M AU - Jensen AB AU - Ahern TP AU - Cronin-Fenton D AU - Ejlertsen B AU - Danish Breast Cancer Group. PY - 2025 JO - Clin Epidemiol DO - 10.2147/clep.s509873 UR - https://doi.org/10.2147/clep.s509873 ER -
APA
S, B., MB, J., CL, B., P, C., BV, O., AR, K., M, E., AB, J., TP, A., D, C., B, E., & Group., D. B. C. (2025). Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo.. Clin Epidemiol. https://doi.org/10.2147/clep.s509873
Source records
- europe-pmc · retrieved 2026-09-26T23:15:09.123Z